Hand cleaning study for premature babies in the NICU
Part of Genetic & congenital, Infections clinical trials.
This study tests if a special hand-cleaning method using chlorhexidine and alcohol can help prevent infections in premature babies (born before 37 weeks) in the newborn intensive care unit (NICU). It aims to see if this cleaning approach is better than the usual method for keeping babies safe from hospital-acquired infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 37 weeks of pregnancy (premature).
- Your baby is currently in the NICU at Alexandria University Children's Hospitals.
- Your baby must be under 72 hours old (3 days) when joining the study.
- Your baby does not have any major birth defects, immune system problems, or inherited metabolic conditions.
- Your baby does not have an infection that started in the first 3 days of life (early-onset sepsis).
- You (the parent or guardian) must agree in writing for your baby to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis recover better. Sepsis is a serious infection in the blood. NAC may reduce inflammation and improve outcomes.
This study looks at whether a blood test called presepsin can help doctors diagnose sepsis (a serious infection) in newborn babies. If it works, it could help doctors start treatment faster and more accurately.
This trial tests whether adding a small amount of chlorine to the drinking water at public health facilities can reduce infections (including those resistant to antibiotics) in newborns. You and your baby may be eligible if you deliver at a participating facility that does not already chlorinate its water.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study looks at a new way to decide if a newborn might have an infection and needs treatment. It may help avoid unnecessary treatments for babies who are not really infected.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
Hear when a new Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.